A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
Condition:   Healthy Participants Interventions:   Drug: BMS-986322;   Drug: Loestrin Sponsor:   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials

The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Condition:   Rheumatoid Arthritis Interventions:   Drug: BMS-986195;   Drug: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2017 Category: Research Source Type: clinical trials

The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Conditions:   Systemic Lupus Erythematosus;   Arthritic Psoriasis;   Psoriasis;   Inflammatory Bowel Diseases Interventions:   Drug: BMS-986165;   Drug: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2017 Category: Research Source Type: clinical trials

The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Condition:   Rheumatoid Arthritis Interventions:   Drug: BMS-986195;   Drug: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2017 Category: Research Source Type: clinical trials